Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465).


Journal

Experimental hematology
ISSN: 1873-2399
Titre abrégé: Exp Hematol
Pays: Netherlands
ID NLM: 0402313

Informations de publication

Date de publication:
07 2019
Historique:
received: 25 12 2018
revised: 24 06 2019
accepted: 26 06 2019
pubmed: 2 7 2019
medline: 19 2 2020
entrez: 2 7 2019
Statut: ppublish

Résumé

Currently, there is a growing need for culturing hematopoietic stem/progenitor cells (HSPCs) in vitro for various clinical applications including gene therapy. Compared with cord blood (CB) CD34

Identifiants

pubmed: 31260717
pii: S0301-472X(19)30801-X
doi: 10.1016/j.exphem.2019.06.473
pmc: PMC6719293
mid: NIHMS1536419
pii:
doi:

Substances chimiques

GATA2 Transcription Factor 0
GATA2 protein, human 0
Histone Deacetylase Inhibitors 0
Hydroxamic Acids 0
SALL4 protein, human 0
Transcription Factors 0
trichostatin A 3X2S926L3Z

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-63.e11

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL095489
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL131477
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197697
Pays : United States

Informations de copyright

Copyright © 2019 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Références

Blood. 2011 Jul 21;118(3):576-85
pubmed: 21602528
Cytotherapy. 2004;6(4):344-55
pubmed: 16146887
Nat Rev Genet. 2011 May;12(5):301-15
pubmed: 21445084
PLoS One. 2010 May 21;5(5):e10766
pubmed: 20505821
Blood. 2000 Jan 1;95(1):102-10
pubmed: 10607692
Ann N Y Acad Sci. 2012 Aug;1266:138-50
pubmed: 22901265
Biol Blood Marrow Transplant. 2014 Apr;20(4):480-9
pubmed: 24374212
Nat Med. 2006 Feb;12(2):240-5
pubmed: 16429146
Blood Adv. 2018 Oct 23;2(20):2766-2779
pubmed: 30348672
Exp Hematol. 2009 Nov;37(11):1364-1377.e4
pubmed: 19744539
Science. 2014 Sep 19;345(6203):1509-12
pubmed: 25237102
Blood. 2005 Oct 15;106(8):2693-9
pubmed: 15976178
Genes Dev. 2012 Nov 15;26(22):2499-511
pubmed: 23105005
Immunity. 2004 Dec;21(6):853-63
pubmed: 15589173
Gene. 2016 Jun 15;584(2):111-9
pubmed: 26892498
Cell Stem Cell. 2011 Apr 8;8(4):445-58
pubmed: 21474107
Transfusion. 2011 Nov;51 Suppl 4:87S-93S
pubmed: 22074632
Exp Hematol. 2002 Jul;30(7):816-23
pubmed: 12135681
Transfusion. 2015 Apr;55(4):864-74
pubmed: 25363624
Nat Med. 2010 Feb;16(2):232-6
pubmed: 20081862
Nat Med. 2010 Apr;16(4):475-82
pubmed: 20305662
Bone Marrow Transplant. 2012 Mar;47(3):342-51
pubmed: 21625224
Stem Cells. 2009 Apr;27(4):796-805
pubmed: 19350679
Transfusion. 2013 May;53(5):1037-49
pubmed: 22934838
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19756-61
pubmed: 19060217
Blood. 2013 Oct 24;122(17):3074-81
pubmed: 23996087
Blood. 2011 Jun 9;117(23):6083-90
pubmed: 21436068
Cell. 2008 Feb 22;132(4):712
pubmed: 18295585
Nat Cell Biol. 2006 Oct;8(10):1114-23
pubmed: 16980957
Nat Med. 2003 Nov;9(11):1423-7
pubmed: 14578882
Biol Blood Marrow Transplant. 1999;5(2):69-76
pubmed: 10371358
Nature. 2008 May 15;453(7193):306-13
pubmed: 18480811
Nat Rev Immunol. 2008 Apr;8(4):290-301
pubmed: 18323850
Bone Marrow Transplant. 2008 May;41(9):771-8
pubmed: 18209724
Science. 2010 Sep 10;329(5997):1345-8
pubmed: 20688981
Cell. 2014 Jun 5;157(6):1262-78
pubmed: 24906146
Blood. 2007 Apr 15;109(8):3570-8
pubmed: 17185465
Blood. 2009 Mar 19;113(12):2661-72
pubmed: 19168794

Auteurs

Hiro Tatetsu (H)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Myriam Armant (M)

Trans Lab, Children's Hospital Boston, Boston, Massachusetts.

Fei Wang (F)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Chong Gao (C)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Shikiko Ueno (S)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Xi Tian (X)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Alex Federation (A)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Jun Qi (J)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

James Bradner (J)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Daniel G Tenen (DG)

Cancer Science Institute of Singapore, National University of Singapore Centre for Translational Medicine, Singapore; Harvard Stem Cell Institute, Boston, Massachusetts.

Li Chai (L)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: lchai@partners.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH